OmidOmidvarMD
Neurology • Long Beach, CAMovement Disorder, Neuroimmunology/Multiple Sclerosis, Dementia & Geriatrics
Physician
Dr. Omidvar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3747 Worsham Ave.
Suite 100
Long Beach, CA 90808Phone+1 562-430-4513Fax+1 562-430-7718
Summary
- Dr. Omid Omidvar is a neurologist in Long Beach, CA and is affiliated with multiple hospitals in the area, including MemorialCare, Long Beach Memorial Medical Center and Los Alamitos Medical Center. He received his medical degree from Other and has been in practice 25 years. He also speaks multiple languages, including Farsi and French. He specializes in movement disorder, neuroimmunology/multiple sclerosis, and dementia & geriatrics and is experienced in general neurology, autonomic disorders, stroke, migraine disorders, and multiple sclerosis.
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterResidency, Neurology, 1995 - 1998
Kirk Kerkorian School of Medicine at UNLVResidency, Internal Medicine, 1994 - 1995
OtherClass of 1992, MD
Certifications & Licensure
CA State Medical License 1996 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2017-2019
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Top MD Consumers Checkbook
Clinical Trials
- Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy Start of enrollment: 2010 Jun 01
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 99 citationsPreclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, Jennifer C Sasaki, René Meisner
Science Translational Medicine. 2022-06-08 - 192 citationsSafety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinica...Joseph Jankovic, Ira J. Goodman, Beth Safirstein, Tonya K. Marmon, Dale Schenk
JAMA Neurology. 2018-10-01 - 63 citationsRandomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxiaTheresa A. Zesiewicz, Frederic Heerinckx, Robert De Jager, Omid Omidvar, Marcus W. Kilpatrick
Movement Disorders. 2018-07-01
Press Mentions
Failure of Once-Promising Alzheimer’s Drug Reinforces Doubts About Amyloid BetaApril 18th, 2019
Alzheimer’s: Local Physicians Brainstorm Preventative MeasuresJune 4th, 2018- As Prevalence of Alzheimer’s Disease Rises with Aging Population, Researchers Seek Therapeutic StrategiesNovember 23rd, 2015
Professional Memberships
- Member
Other Languages
- Farsi, French
External Links
- Southland Neurologic Associateshttp://www.myneurologists.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
